Jasper Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
March 04, 2024 at 07:40 am EST
Jasper Therapeutics, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 16.58 million compared to USD 13.21 million a year ago. Basic loss per share from continuing operations was USD 1.5 compared to USD 3.6 a year ago.
For the full year, the company reported net loss was USD 64.47 million compared to USD 37.69 million a year ago. Basic loss per share from continuing operations was USD 6.18 compared to USD 10.33 a year ago.